According to The Insight Partners market research study titled “Hematology Analyzers and Reagents Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product and Service, Application, and End User,” The report highlights the trends prevailing in the global hematology analyzers and reagents market and the factors driving the market along with those that act as deterrents to its growth.
Increasing incidence of hematologic diseases and technological advancements in hematology analyzers are anticipated to drive the market growth during the forecast period. However, steep prices of high-tier systems are likely to restrain the market growth.
Strategic Insights:
|
Report Coverage |
Details |
|
Market Size Value in |
(US$ 7,252.54 Million in 2019) |
|
Market Size Value by |
(US$ 13,007.87 Million by 2027) |
|
Growth Rate |
(CAGR of 7.6% from 2020-2027) |
|
Forecast Period |
(2020-2027) |
|
Base Year |
(2020) |
|
No. of Pages |
(229) |
|
No. Tables |
(162) |
|
Segments covered |
(Product and Service ; Application ; End User , and Geography) |
|
Regional scope |
(North America; Europe; Asia Pacific; Latin America; MEA) |
|
Country scope |
(US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina) |
|
Report coverage |
(Revenue forecast, company ranking, competitive landscape, growth factors, and trends) |
Get Sample PDF Copy Along with TOC of Hematology Analyzers and Reagents Market at: https://www.theinsightpartners.com/sample/TIPRE00003261/
Hematology analyzers & reagents are healthcare products and consumables intended to identify and count the individual blood cells in a high-speed manner and highly effective. These instruments have substituted the conventional methods of measuring blood cells individually under a microscope, which were previously carried out by the lab technicians. These devices provide more precise and useful blood cell results and other related information from the blood sample.
Technological Advancements in Hematology Analyzers
The players operating in the hematology analyzers and reagents market are highly competitive and have been introducing novel products and reagents. For instance, in May 2020, Beckman Coulter introduced DxH 690T hematology analyzer in the US to streamline workflow as well as minimize the downtime in medium-sized laboratories. Moreover, in August 2020, IDEXX Laboratories, Inc. introduced ProCyte OneHematology Analyzer that helps to deliver workflows with simplicity and consistency at the point of care. The company has also announced its plans for the global rollout of this product by early 2021. In addition, in July 2017, Sysmex launched the XN-L automated hematology analyzers in the US. Later in September 2018, it also launched XS-500ix in the Chinese market; the new product is an automated hematology analyzer of its XS-Series. Furthermore, in September 2020, Agappe Diagnostics, in collaboration with L&T Technology Services Limited, introduced its first indigenously developed hematology analyzer Mispa Count X. The launches of such new products are fueling the growth of the hematology analyzers and reagents market.
Anemia is a common blood disorder, and according to the National Heart, Lung, and Blood Institute, it affects more than 3 million Americans every year. Moreover, according to the World Health Organization (WHO), the disorder affected ~1.62 billion people worldwide in 2018. Anemia is also prevalent in Indian population and affects the quality of life of a remarkable number of people. According to the National Family Health Survey (NFHS) conducted in India in 2018, anemia affected ~58.6% of children and 50.4% of pregnant women in the country in 2016. Further, according to the Centers of Disease Control and Prevention (CDC), hemophilia A affects ~1 in 5,000 male births in the US on an average each year. A CDC survey for 2017 reported that VWD, one of the most common bleeding disorders, affects up to 1% of the general population. During 2012–2016, more than 14,600 men, women, and children were seen at hemophilia treatment centers for treatment of VWD. The increasing incidence of blood-related diseases is augmenting the growth of the hematology analyzers and reagents market.
The COVID-19 pandemic is estimated to have a significant positive impact on the hematology analyzers and reagents market. Majority of the pharmaceutical companies across the world are engaged in the development of vaccines for COVID-19. Moreover, companies are now focusing on the development of the antibody-specific COVID-19 blood tests, which is anticipated to have a positive impact on the other segments of the market in the coming months. However, disruptions in the supply chain caused due to the halt in global operations are hindering the market growth.
Download the Latest COVID-19 Analysis on Hematology Analyzers and Reagents Market Growth Research Report at: https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00003261
Based on product and service, the global hematology analyzers and reagents market is segmented into hematology products and services, hemostasis products and services, and immunohematology products and services. In 2019, the hematology products and services segment held the largest market share. The same segment is also expected to dominate the market by 2027 as it has diverse testing volumes that helps deliver accurate results. Moreover, these instruments are generally used in medical laboratories to detect protein or enzymes, and count blood cells in order to help in the diagnosis of illness and genetic defects.
Hematology Analyzers and Reagents Market: Competitive Landscape and Key Developments
A few prominent players operating in the hematology analyzers and reagents market are Clinical Diagnostic Solutions, Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Danaher; BIO-RAD LABORATORIES INC.; Abbott; Diatron; ERBA Diagnostics Inc.; EKF Diagnostics; HORIBA Medical; and Biosystems S.A.
Order a Copy of Hematology Analyzers and Reagents Market Shares, Strategies and Forecasts 2021-2028 Research Report at: https://www.theinsightpartners.com/buy/TIPRE00003261/
Market players are bringing new and innovative products and services to sustain their position in the hematology analyzers and reagents market. For instance, in January 2020, Beckman Coulter launched the DxH 560 AL, a tabletop analyzer geared to reduce the time and resource constraints faced by small to mid-sized laboratories. Such developments are expected to bolster the market growth during the forecast period.
The report segments the global Hematology Analyzers and Reagents market as follows:
Hematology Analyzers and Reagents Market – by Product and Service
- Hematology Product and Services
- Instruments
- Reagents and Consumables
- Services
- Hemostasis Product and Services
- Instruments
- Reagents and Consumables
- Services
- Immunohematology Product and Services
- Instruments
- Reagents and Consumables
- Services
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Media Contact
Company Name: The Insight Partners
Contact Person: Sameer Joshi
Email: Send Email
Phone: +1-646-491-9876
City: Pune
State: Maharashtra
Country: India
Website: https://www.theinsightpartners.com/pr/hematology-analyzers-and-reagents-market